Profusa Inc. (Nasdaq: PFSA), a digital health company, has taken a bold step into digital assets with the announcement of a $100 million equity line of credit (ELOC) with Ascent Partners Fund, with all net proceeds, subject to a $5 million cash floor, allocated to bitcoin purchases.

Under the agreement, Ascent will purchase Profusa’s common stock at 97% of the lowest volume-weighted average price over the five trading days post-issuance. The company can raise up to $5 million per drawdown, limited by recent average trading volumes.

Ben Hwang, Profusa’s Chairman and CEO, shared the company’s new treasury management strategy.

It is critical that we leverage opportunities to manage our resources to enable maximum shareholder value. Holding bitcoin on our balance sheet represents a strategic move to safeguard shareholder value and align with a digital future.

The move positions bitcoin as Profusa’s primary treasury reserve asset. If the company’s cash balance falls below $5 million, proceeds from the ELOC will first replenish cash reserves before being used to acquire BTC. Profusa expects its first bitcoin purchases to take place this week and will report its holdings quarterly.

This marks a significant treasury pivot for a public biotech firm, signaling growing institutional interest in bitcoin as a financial reserve tool beyond the tech sector.

免责声明：本文章仅代表作者个人观点，不代表本平台的立场和观点。本文章仅供信息分享，不构成对任何人的任何投资建议。用户与作者之间的任何争议，与本平台无关。如网页中刊载的文章或图片涉及侵权，请提供相关的权利证明和身份证明发送邮件到support@aicoin.com，本平台相关工作人员将会进行核查。